about
Interferon-Free Treatments for Chronic Hepatitis C Genotype 1 InfectionNS5B polymerase inhibitors in phase II clinical trials for HCV infection.Effects of a Fixed-Dose Co-Formulation of Daclatasvir, Asunaprevir, and Beclabuvir on the Pharmacokinetics of a Cocktail of Cytochrome P450 and Drug Transporter Substrates in Healthy Subjects.
P2860
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Beclabuvir for the treatment of hepatitis C.
@en
type
label
Beclabuvir for the treatment of hepatitis C.
@en
prefLabel
Beclabuvir for the treatment of hepatitis C.
@en
P2093
P2860
P1476
Beclabuvir for the treatment of hepatitis C
@en
P2093
Alberto Enrico Maraolo
Antonio Riccardo Buonomo
Guglielmo Borgia
Ivan Gentile
P2860
P304
P356
10.1517/13543784.2015.1059820
P407
P577
2015-07-09T00:00:00Z